New and Future Treatments of Blood Cancer Flashcards

1
Q

how do chemo and radiotherapy work generally?

A

damages DNA of cancer cells as they divide (Mitosis)

cell recognises it is damaged beyond repair and undergoes apoptosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

mutations in which genes make it more difficult to treat with chemo or radiotherapy?

A

P53

CLL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

how does dose of chemo/radiotherapy affect method of cell death?

A

lower dose = apoptosis (cell breaks into several parts which are phagocytosed, no inflammation)
higher dose = necrosis (membrane ruptures causing cell lysis and inflammation)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

why do lymphoma/CLL and acute leukaemia respond better to chemo and RT then most cancers?

A

lymphocytes are keen to undergo apoptosis in the normal lymph node
therefore lymphoma and CLL cells can be triggered to undergo apoptosis readily with chemo/radiotherapy
acute leukaemia is dividing quickly so more cells dividing and so are more affected by chemo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

side effects of chemo/RT?

A

normal cells also affected so undergo apoptosis
immediate effects = hair loss, nausea and vomiting, neutropenic infection, extreme tiredness
long term effects = heart/lung damage, other cancers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what supportive factors are used in treatment of blood cancer?

A
prompt treatment of neutropenic infection
broad spectrum antibiotics
RBC and platelet transfusion
growth factors (G-CSF)
prophylactic antibiotics and antifungals
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

guidelines for management of neutropenic sepsis if standard risk (NEWS <6)?

A

assess within 15 mins
piperacillin/tazobactam or teicoplanin + aztreonam if penicillin allergic
teicoplanin + ciprofloxacin if anaphylaxis or angioedema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

guidelines for management of neutropenic sepsis if high risk (NEWS >6)?

A

assess within 15 mins
piperacillin/tazobactam + gentamicin
teicoplanin + aztreonam + gentamicin if penicillin allergic
teicoplanin + ciprofloxacin + gentamicin if anaphylaxis or angioedema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

how soon should antibiotics be started in neutropenic sepsis?

A

1 hr

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what prophylactic antifungals are given to all at risk?

A

itraconazole or posaconazole

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

how can dosing of chemo be altered to fit case?

A

increased dose in those who need it for cure and accept side effects
reduced or missed doses in those who don’t need it to avoid long term side effects
(can use PET scan to help decide)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

how effective is ABVD chemo in hodgkins?

A

very likely to be cured

side effects can be avoided by missing out bleomycin in cycles 3-6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

types of targeted therapy in blood cancer?

A

monoclonal antibodies
biological agents
molecularly targeted treatments

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

describe how monoclonal antibodies are used

A

type of immune treatment which affects only cells which possess target protein
most are currently used in combination with chemo
more effective than chemo alone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

give an example of monoclonal antibody

A

rituximab (mouse/human chimeric monoclonal antibody)
type of IgG
variable region binds to CD20 on B cells
“naked antibody”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

other B cell antibodies used in blood cancer?

A

ofatumunam (azerra)

obinutumab (gazyvaro)

17
Q

how do other B cell antibodies differ from rituximab in treatment of blood cancer?

A

more direct kill of malignant B cells

better than rituximab in CLL in less fit patients alongside gentle chemo

18
Q

what is brentuximab vedotin?

A

conjugate drug made of biologics and anti CD30 monoclonal antitbody

19
Q

examples of biological treatments?

A

proteasome inhibitors and IMIDs

20
Q

when are biological treatments used?

A

currently in multiple myeloma and being evaluated in lymphoma

21
Q

how do proteasome inhibitors work?

A

proteasome = bin for old proteins inside the cell, breaks them down into amino acids for recycling
therefore blocking proteasome allows accumulation of toxic proteins in cell causing apoptosis

22
Q

side effects of proteasome inhibitors?

A

nerve damage and low platelets

23
Q

what are IMIDs?

A

derivatives of thalidomide

mode of action poorly understood

24
Q

how are IMIDs used?

A

can produce remission in some with low grade NHL and CLL which no longer respond to chemo
slightly better when in combination with chemo then chemo alone in mantle cell NHL

25
Q

side effects of IMIDs?

A

nerve damage
risk to foetus
effect on blood counts
other cancers

26
Q

aims of molecular/targeted treatments?

A

target pathway specific to the cancer cell
avoid side effects
more effective than chemo

27
Q

examples of molecular/targeted treatments?

A

tyrosine kinase inhibitors in CML
targeting malignant B cells in CLL/NHL
stopping tumours evade immune system

28
Q

effects of tyrosine kinase inhibitors on CML?

A

normal blood counts
normal chromosomes
no detectable BCR-ABL in blood
usually well tolerated but can cause diarrhoea and fluid in lungs and neutropenia

29
Q

how do drugs affecting B cell signalling pathways work?

A

CLL and lymphoma cells have abnormally active signalling mechanisms inside cells
blockage of these signalling proteins can cause apoptosis even if P53 is abnormal

30
Q

examples of drugs which affect B cell signalling pathways?

A

ibrutinib (imbuvica)

idelalisib (zydelig)

31
Q

how are ibrutinib and idelalisib used?

A

effective in low grade NHL and B cell CLL that don’t respond to rituximab and chemo
idelalisib approved for use in CLL with P53 mutation

32
Q

side effects if ibrutinib and idelalisib?

A
ibrutinib = fever, low platelets, anaemia, SOB
idelalisib = diarrhoea, rash, fatigue, liver abnormality, fever
33
Q

example of a checkpoint inhibitor?

A

nivolumab

used in malignant melanoma, even more in lymphoma (esp hidkins disease)

34
Q

how do checkpoint inhibitors work?

A

cancer cells avoid cells of the immune system by producing chemicals that bind to receptors on surface of immune cells called PD-1 receptors
stimulation of receptor causes cell to switch off and ignore the tumour cells (immune evasion)
nivolumab sticks to this chemical and stops it binding to the effector cell so the immune system remains switched on and attacks the cancer cell

35
Q

side effects of nivolumab?

A
rash
low platelets
fatigue
pyrexia
diarrhoea
nausea
pruritic
cough
hypothyroid
36
Q

how is immune therapy used in blood cancer?

A

allogenic bone marrow transplant from matched donor
T cells from donor cause immune attack on cancer
graft vs leukaemia/lymphoma effect
also have attack of normal cells however (graft vs host disease)

37
Q

what is adoptive immunotherapy?

A

new type of immunotherapy in development where you make the patient’s own immune cells recognise the cancer as foreign and attack it
avoids toxicity of graft vs host disease
(most promising type = CAR T cell therapy)